Fact CheckerSign in

NCT07277595Not yet recruiting

kTMP in Chronic Stroke

KTMP: A Novel Method of Non-invasive Brain Stimulation to Enhance Motor Function in Chronic Stroke Patients.

Source: ClinicalTrials.gov · Last updated 6 May 2026

Brief summary (registry, in English)

kTMP, kilohertz transcutaneous magnetic perturbations, is a low intensity transcranial magnetic stimulation technique that will be used in this study to promote arm/hand rehabilitation in patients who have been disabled by stroke.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
100 (estimated)
First submitted
2 Dec 2025
Start date
1 Jul 2026
Primary completion date
1 Aug 2030
Lead sponsor
University of California, San Francisco
Diseases
Stroke
NCT number
NCT07277595

What you commit to

  • Study type: Interventional
  • Planned participants: 100
  • From 1 Jul 2026 to the primary completion date, 1 Aug 2030
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Significant cognitive impairment

Other

  • inability to adhere to the study protocol or provide informed consent
  • pregnancy
  • additional criteria may apply

Who the study is looking for

  • Adults age 18-80 years old who have had a stroke resulting in hemiplegia
  • Ability to communicate, understand, and give appropriate consent
  • Other criteria may apply

Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of California San Francisco
Coordinator of this site? Confirm its status		San FranciscoUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.